{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:20:36Z","timestamp":1791390036705,"version":"4.3.3"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 AI169066"],"award-info":[{"award-number":["R01 AI169066"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA021765"],"award-info":[{"award-number":["P30 CA021765"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cmi.2025.10.009","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T16:01:15Z","timestamp":1760803275000},"page":"285-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Relative contributions of the ERG11VF125AL and MRR1AN647T mutations to fluconazole resistance in Clade III Candidozyma (Candida) auris clinical isolates"],"prefix":"10.1016","volume":"32","author":[{"given":"Katherine S.","family":"Barker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy L.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Rybak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Morschh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A.","family":"Cuomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. David","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2025.10.009_bib1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41579-023-00960-9","article-title":"The rapid emergence of antifungal-resistant human-pathogenic fungi","volume":"21","author":"Lockhart","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cmi.2025.10.009_bib2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.7326\/M22-3469","article-title":"Worsening spread of Candida auris in the United States, 2019 to 2021","volume":"176","author":"Lyman","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2025.10.009_bib3","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2019. Atlanta (GA): U.S. Department of Health and Human Services, CDC; 2019. http:\/\/cdc.gov\/antimicrobial-resistance\/media\/pdfs\/2019-ar-threats-report-508.pdf. (accessed February 21, 2025)."},{"key":"10.1016\/j.cmi.2025.10.009_bib4","unstructured":"World Health Organization. WHO fungal priority pathogens list to guide research, development, and public health action. Geneva (Switzerland): World Health Organization; 2022. http:\/\/who.int\/publications\/i\/item\/9789240060241\/ (accessed February 21, 2025)."},{"key":"10.1016\/j.cmi.2025.10.009_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2022.102208","article-title":"The molecular and genetic basis of antifungal resistance in the emerging fungal pathogen Candida auris","volume":"70","author":"Rybak","year":"2022","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.cmi.2025.10.009_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00057-19","article-title":"Abrogation of triazole resistance upon deletion of cdr1 in a clinical isolate of Candida auris","volume":"63","author":"Rybak","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.10.009_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.01585-21","article-title":"Delineation of the direct contribution of Candida auris erg11 mutations to clinical triazole resistance","volume":"9","author":"Rybak","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.cmi.2025.10.009_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00365-20","article-title":"Mutations in tac1b: A novel genetic determinant of clinical fluconazole resistance in Candida auris","volume":"11","author":"Rybak","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.cmi.2025.10.009_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00300-25","article-title":"Mutations in TAC1B drive CDR1 and MDR1 expression and azole resistance in Candida auris","volume":"69","author":"Barker","year":"2025","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.cmi.2025.10.009_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0030164","article-title":"The transcription factor mrr1p controls expression of the mdr1 efflux pump and mediates multidrug resistance in Candida albicans","volume":"3","author":"Morschh\u00e4user","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2025.10.009_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00279-20","article-title":"A zinc cluster transcription factor contributes to the intrinsic fluconazole resistance of Candida auris","volume":"5","author":"Mayr","year":"2020","journal-title":"mSphere"},{"key":"10.1016\/j.cmi.2025.10.009_bib12","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1038\/s41467-020-20183-3","article-title":"An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris","volume":"11","author":"Iyer","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2025.10.009_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00067-22","article-title":"Deciphering the mrr1\/mdr1 pathway in azole resistance of Candida auris","volume":"66","author":"Li","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.10.009_bib14","unstructured":"Centers for Disease Control and Prevention. Antifungal Susceptibility Testing for Candida auris (C. auris). Atlanta (GA): U.S. Department of Health and Human Services, CDC. https:\/\/www.cdc.gov\/candida-auris\/hcp\/laboratories\/antifungal-susceptibility-testing.html. [Accessed 23 April 2024]."},{"key":"10.1016\/j.cmi.2025.10.009_bib15","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1038\/s41467-021-27545-5","article-title":"Forward and reverse genetic dissection of morphogenesis identifies filament-competent Candida auris strains","volume":"12","author":"Santana","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2025.10.009_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/myc.13022","article-title":"Candida auris in various hospitals across kuwait and their susceptibility and molecular basis of resistance to antifungal drugs","volume":"63","author":"Ahmad","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2025.10.009_bib17","first-page":"171","article-title":"Y132h substitution in Candida albicans sterol 14alpha-demethylase confers fluconazole resistance by preventing binding to haem","volume":"180","author":"Kelly","year":"1999","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.cmi.2025.10.009_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/bbrc.1999.1136","article-title":"The G464S amino acid substitution in Candida albicans sterol 14alpha-demethylase causes fluconazole resistance in the clinic through reduced affinity","volume":"262","author":"Kelly","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cmi.2025.10.009_bib19","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1128\/AAC.05389-11","article-title":"S279 point mutations in Candida albicans sterol 14-\u03b1 demethylase (cyp51) reduce in vitro inhibition by fluconazole","volume":"56","author":"Warrilow","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.10.009_bib20","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1128\/EC.00103-08","article-title":"A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate","volume":"7","author":"Dunkel","year":"2008","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.cmi.2025.10.009_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/AAC.01102-09","article-title":"An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans","volume":"54","author":"Heilmann","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.10.009_bib22","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AAC.39.11.2378","article-title":"Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from aids patients involve specific multidrug transporters","volume":"39","author":"Sanglard","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.10.009_bib23","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1128\/AAC.40.10.2300","article-title":"Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors","volume":"40","author":"Sanglard","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.10.009_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00289-22","article-title":"Candida parapsilosis MDR1B and CDR1B are drivers of MRR1-mediated clinical fluconazole resistance","volume":"66","author":"Doorley","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.10.009_bib25","doi-asserted-by":"crossref","first-page":"12040","DOI":"10.1073\/pnas.1807698115","article-title":"Evolution of drug resistance in an antifungal-naive chronic Candida lusitaniae infection","volume":"115","author":"Demers","year":"2018","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25005105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25005105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:41:13Z","timestamp":1773924073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X25005105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1198743X25005105"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2025.10.009","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relative contributions of the ERG11VF125AL and MRR1AN647T mutations to fluconazole resistance in Clade III Candidozyma (Candida) auris clinical isolates","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}